Global Metabolomics Market Analysis Report to 2029 - Featuring Thermo Fisher Scientific, Agilent Technologies, Waters and Danaher Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Metabolomics Market Analysis by Product, by Application, by Indication, by End Use, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The global metabolomics market size is estimated to be USD 1,986.5 Million in 2021 and is expected to witness a CAGR of 17.81% during the forecast period.
Availability of government and private funding for metabolomics research is a key driver for the growth of the global metabolomics market.
Additionally, increasing pharmaceutical and biotech R&D expenditure and growing demand for personalized medicine are some of the other drivers propelling the market growth.
Nevertheless, complexity and diversity of biological samples and high cost of tools & instruments are expected to restrain the global market growth
Companies Mentioned
- Thermo Fisher Scientific (U.S.)
- Agilent Technologies (U.S.)
- Waters Corporation (U.S.)
- Danaher Corporation (U.S.)
- Shimadzu Corporation (Japan)
- Bio-Rad Laboratories (U.S.)
- Bruker Corporation (U.S.)
- PerkinElmer Inc. (U.S.)
- Merck KGaA (Germany)
- GE Healthcare (U.S.)
Metabolomics Market, By Product and Service (Revenue, 2021-2029, USD Million)
Bioinformatics Tools & Services
Bioinformatics Services
- Bioinformatics Tools & Databases
Instruments
Separation Tools
- High-Performance Liquid Chromatography
- Gas Chromatography
- Ultra-Performance Liquid Chromatography
- Capillary Electrophoresis
- Detection Tools
- Mass Spectrometry
- Nuclear Magnetic Resonance Spectroscopy
- Surface-Based Mass Analysis
Metabolomics Market, By Application (Revenue, 2021-2029, USD Million)
- Drug Discovery
- Biomarker Discovery
- Nutrigenomics
- Toxicology Testing
- Functional Genomics
- Personalized Medicine
- Other Applications
Metabolomics Market, By Indication (Revenue, 2021-2029, USD Million)
- Neurological Disorders
- Metabolic Disorders
- Cancer
- Cardiovascular Disorders
- Inborn Errors of Metabolism
- Others
Metabolomics Market, By End User (Revenue, 2021-2029, USD Million)
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations (CROS)
- Others
Metabolomics Market, By Region (Revenue, 2021-2029, USD Million)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/2rk2oq
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Editor Details
-
Company:
- Businesswire